• Mashup Score: 1
    03/28/2022 - 2 year(s) ago

    Clearside Investor and Media Contacts: Jenny Kobin Remy Bernarda ir@clearsidebio.com (678) 430-8206   Bausch Health Investor Contact: Arthur Shannon arthur.shannon@bauschhealth.com (514) 865-3855 (877) 281-6642 (toll free) Bausch Health Media Contact: Lainie Keller lainie.keller@bauschhealth.com (908) 927-1198 BAUSCH + LOMB AND CLEARSIDE BIOMEDICAL ANNOUNCE THE U.S….

    Tweet Tweets with this article
    • NEWS: @BauschLomb today announced the U.S. commercial launch of XIPERE®. The launch comes after #FDA approval in October 2021. https://t.co/w2Uk0079n2 #Ophthalmology #Clinical #Treatment #Uveitis